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Abstract
Background: Robotic distal pancreatectomy (RDP) is performed increasingly, but knowledge of the
number of cases required to attain procedural proficiency is lacking. The aim of this study was to iden-
tify the learning curve associated with RDP at a high-volume pancreatic centre.
Methods: Metrics of perioperative safety and efficiency for all consecutive RDPs were evaluated. Out-
comes were followed to 90 days. Cumulative sum (CUSUM) analysis was used to identify inflexion
points corresponding to the learning curve.
Results: Between 2008 and 2013, 100 patients underwent RDP. There was no 90-day mortality. In
two patients (2.0%), surgery was converted to laparotomy. Thirty procedures were performed for pan-
creatic adenocarcinoma. Precipitous operative time reductions from an initial operative time of 331 min
were observed after the first 20 and 40 cases to 266 min and 210 min, respectively (P < 0.0001). The
likelihood of readmission was significantly lower after the first 40 cases (P = 0.04), and non-significant
reductions were observed in incidences of major (Clavien–Dindo Grade II or higher) morbidity and
Grade B and C leaks, and length of stay.
Conclusions: In this experience, RDP outcomes were optimized after 40 cases. Familiarity with the
platform and dedicated training are likely to contribute to significantly shorter learning curves in future
adopters.
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Introduction
Laparoscopic distal pancreatectomy (LDP) is associated with
reductions in blood loss, analgesic requirements, hospital stay
and morbidity compared with the open approach.1–7 Similarly,
robotic distal pancreatectomy (RDP) has been demonstrated
to be equally safe and effective, and to confer benefits similar
to those associated with laparoscopic surgery.8–11 However,
RDP may also allow for substantial reductions in blood loss
(> 500 ml) and rates of conversion to open surgery, particu-
larly when it is performed for cancer.8,11 Additionally, the
costs associated with RDP may become comparable with those
of the open or laparoscopic approaches when reductions in
conversions translate into reduced hospital lengths of stay
(LoS).9
The benefits of minimally invasive distal pancreatectomy
(DP),7,12 coupled with the advantageous ergonomics of the
robotic platform, have led more surgeons to attempt RDP
for the treatment of benign and malignant disease.13,14 As for
other procedures, a learning curve may exist for RDP, which,
if identified, may allow new adopters the insight and benefit
of prior experiences. For RDP, this learning curve entails the
mastery of important facets unique to the use of robotic
technology, including optimal port placement, the develop-
ment of close coordination between the console surgeon and
bedside assistant, and the overcoming of the loss of tactile
feedback.
The present paper reports the outcomes of the first 100 con-
secutive RDPs to be performed at one centre with the aim of
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identifying major inflexion points and milestones in the
optimization of perioperative outcomes.
Materials and methods
Design and study population
A retrospective (institutional review board-approved) review of
a prospectively maintained database of all RDP procedures car-
ried out at the University of Pittsburgh from August 2008,
when the gastrointestinal robotic programme at the University
of Pittsburgh Medical Center (UPMC) was implemented, to
July 2013 was performed. The cohort consisted of the first 100
consecutive cases to be operated using the Da Vinci S or Si
Surgical System (Intuitive Surgical, Inc., Sunnyvale, CA, USA).
Three surgeons (HJZ, AJM and AHZ) performed 86.0% of all
RDPs in this cohort. These three surgeons had extensive prior
experience with LDP, but no substantial prior robotic experi-
ence. Contraindications to RDP at the study institution
evolved significantly over the study period, but from 2011 were
limited to: (i) pancreatic body tumours involving the spleno-
portal confluence for which the resection and reconstruction of
the superior mesenteric vein and/or portal vein were antici-
pated, and (ii) tumours for which a negative margin resection
was anticipated to require large multivisceral resections.
Importantly, patients with neoadjuvant therapy, anticipated
‘side-bite’ resections of the splenoportal confluence or concom-
itant ‘minor’ resections of adjacent viscera (adrenalectomy,
partial colectomy, duodenectomy, gastrectomy) were not
excluded from the robotic approach.
Operative technique
The technique for RDP used at this institution has been pub-
lished previously.2,11 Initial laparoscopic mobilization is limited
to: (i) mobilization of the greater curvature of the stomach up
to the angle of His cranially and the right gastroepiploic pedi-
cle inferiorly, and (ii) lowering of the splenic flexure. The
remainder of the operation is performed robotically. Splenic
preservation was performed according to surgeon preference.
When performed for pancreatic ductal adenocarcinoma (PDA),
en bloc resection of the retroperitoneal fascia according to the
method described by Strasberg and Fields15 was used. Intraop-
erative frozen-section margins of the pancreatic neck were rou-
tinely performed. A closed suction drain was used in all cases.
Definitions and statistical analysis
Procedure duration was calculated as the length of time
between skin incision and closure, including the time required
to dock the robot. Postoperative outcomes were followed to
90 days. Postoperative pancreatic fistula (POPF) was defined
according to International Study Group on Pancreatic Fistula
(ISGPF) criteria16 and complications were graded according to
the Clavien–Dindo system of classification.17,18 Analysis was
performed on an intent-to-treat basis. Student’s t-test and
analysis of variance (ANOVA) were used to compare normally
distributed variables between groups. The Wilcoxon rank-sum
test and Kruskal–Wallis test were used for non-normally dis-
tributed variables. Fisher’s exact test was used to compare cate-
gorical variables between groups. A P-value of <0.05 was
considered to indicate statistical significance. All statistical
analyses were performed using STATA Version 10 (StataCorp LP,
College Station, TX, USA).
Cumulative sum analysis of operative time
Cumulative sum (CUSUM) analysis was used to define the
learning curve. CUSUM is the accumulated total difference
between each data point and the mean of all data points for a
particular metric. It is well suited to and widely employed in
the assessment of new technical skills.19–21 Starting with the
earliest surgical date, cases were ordered chronologically; the
difference between the operative time (OT) of each of the 100
cases and the mean OT of all cases (lOT) was then obtained.
The CUSUMOT was obtained by adding up the calculated dif-
ference from the overall mean, starting with the first case to
the next cumulatively. If the OT for a case is more than lOT,
the addition to the running value of CUSUMORT is a positive
number (upwards slope on the graph). Conversely, it is a nega-
tive number if the OT for a case is less than lOT (downwards
slope). This cumulative process is sustained until CUSUMORT
for the last case is calculated as zero. This allows for a graphi-
cal representation of the learning curve and simultaneously
outlines deviations from the OT norm.
Results
Perioperative outcomes for the entire cohort
Table 1 demonstrates preoperative parameters for the entire
cohort (n = 100). The mean age of the patients was 60 years.
A total of 58.0% were female and 66.0% of patients had
undergone prior abdominal surgery. Indications for RDP
included neuroendocrine tumour (n = 35), PDA (n = 30),
chronic pancreatitis or benign or premalignant cystic disease
(n = 30), and metastatic lesions (n = 5). Table 2 displays oper-
ative and postoperative outcomes. The average OT was
246 min and the median estimated blood loss (EBL) was
150 ml. Two patients (2.0%) required conversion to laparot-
omy for failure to progress in a large 11-cm mucinous cystic
neoplasm (MCN) (case 41), and significant adhesions (case
47). No 90-day mortalities were recorded. Clavien–Dindo
Grade III and IV complications occurred in 14.0% of patients
and POPF occurred in 42.0% (Grade A, 24.0%; Grade B,
13.0%; Grade C, 5.0%).
Identification of learning curve based on CUSUM OT
An analysis of all perioperative outcomes was performed by
grouping patients chronologically into 10 groups (data not
shown). This analysis revealed OT as the only variable to exhi-
bit improvement across the 10 groups. A significant reduction
in OT was observed after the first 40 cases (from 298 min to
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Table 1 Demographics and preoperative characteristics for 100 robotic distal pancreatectomies (RDPs) and the first 40 versus the last
60 RDPs
Parameter Total
n = 100
Early experience
n = 40
Late experience
n = 60
P-value
Age, years, mean  SD 60.13  12.7 60.1  14.1 60.2  11.8 0.985
Female, n (%) 58 (58.0%) 25 (62.5%) 33 (55.0%) 0.537
Preoperative BMI, kg/m2, mean  SD 29.9  7.2 29.3  7.1 30.3  7.2 0.506
Prior surgery, n (%) 66 (66.0%) 28 (70.0%) 38 (63.3%) 0.525
ASA class, n (%)
2 27 (27.0%) 12 (30.0%) 15 (25.0%) 0.565
3 71 (71.0%) 28 (70.0%) 43 (71.7%)
4 2 (2.0%) 0 2 (3.3%)
CCI, mean  SD 3.7  2.9 3.7  3.2 3.7  2.8 0.890
Preoperative albumin, mean  SD 3.8  0.50 3.8  0.54 3.9  0.48 0.403
CT size, cm, mean  SD 3.1  2.4 3.2  2.3 3.1  2.5 0.974
EUS size, cm, mean  SD 3.4  2.6 3.8  2.8 3.1  2.4 0.198
PDA, n (%) 30 (30.0%) 16 (40.0%) 14 (23.3%) 0.118
ASA, American Society of Anesthesiologists; BMI, body mass index; CCI, charlson comorbidity index; CT, computerized tomography scan; EUS,
endoscopic ultrasound; PDA, pancreatic ductal adenocarcinoma; SD, standard deviation.
Table 2 Operative and postoperative outcomes in 100 robotic distal pancreatectomies (RDPs) and in the first 40 and the last 60 RDPs
Totala
n = 100
Early experienceb
n = 40
Late experiencec
n = 60
P-value
OR time, min, mean  SD 245.7  89.5 298.6  92.9 210.4  67.5 <0.0001
Pure RDP time, min, mean  SD 236  79 283  87 205  56 <0.0001
RDP with additional resections, min, mean  SD 291  119 361  97 236  109 <0.05
EBL, ml, median (IQR) 150 (100–300) 175 (100–300) 150 (100–300) 0.670
Conversion, n (%) 2 (20.0%) 0 2 (3.3%) 0.515
Postoperative transfusion, n (%) 4 (4.0%) 3 (7.5%) 1 (6.7%) 0.299
Mortality, n 0 0 0 1
Any complication, n (%) 72 (72.0%) 29 (72.5%) 43 (71.7%) 1
Complications, Clavien Grade >II, n (%) 14 (14.0%) 8 (20.0%) 6 (10.0%) 0.239
Reoperation, n (%) 1 (1.0%) 0 1 (1.7%) 1.00
All pancreatic leaks, n (%) 42 (42.0%) 18 (45.0%) 24 (40.0%) 0.682
POPF Grades B and C, n (%) 18 (18.0%) 11 (27.5%) 7 (11.7%) 0.062
Readmission, n (%) 28 (28.0%) 16 (40.0%)d 12 (20.0%)e 0.041
Length of stay, days, median (IQR) 6 (5–8) 6 (5–6) 5 (4.5–6) 0.672
Lymph node count (malignant cases), median (IQR) 12.5 (10–22) 16 (8–20.5) 15.5 (10–24) 0.475
Positive margin,f n (%) 3 (4.3%) 1 (3.1%) 2 (5.3%) 1.00
a
The 100 RDPs included 82 pure RDPs and 18 RDPs with additional procedures (cholecystectomy, n = 6; duodenal/gastric resection, n = 5; liver
radiofrequency ablation, n = 3; adrenalectomy, n = 2; colectomy, n = 1; inferior vena cava filter placement, n = 1).
b
Early experience (n = 40) included 32 pure RDPs and eight RDPs with concomitant resection.
c
Late experience (n = 60) included 50 pure RDPs and 10 RDPs with concomitant resection.
d
Reasons for the 16 (early experience) readmissions were: fluid collections (n = 8; all had Grade B or C leaks);fever (n = 2; both had Grade B
leaks but no collection); nausea/pain (n = 2; both had Grade A leaks), postoperative haematoma (self-limiting) (n = 2), seizure activity (no leak)
(n = 1), and superficial wound infection (n = 1).
e
Reasons for the 12 (late experience) readmissions: fluid collection (n = 4; Grade B, n = 3; Grade A, n = 1), fever (n = 3; Grade B leak but no col-
lections), postoperative pain/constipation (no leak or collections) (n = 2), poorly controlled new postoperative diabetes (n = 2), Clostridium difficile
(n = 1), and flu-like symptoms (n = 1).
f
70 total malignancy cases; 32 in early experience, and 38 in late experience.
P-values in bold are significant at <0.05.
EBL, estimated blood loss; IQR, interquartile range; OR, operating room; POPF, postoperative pancreatic fistula; SD, standard deviation.
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210 min; P < 0.0001) (Fig. 1). Further analysis revealed two
distinct inflexion points within these 40 cases; reductions in
OT were observed between the first two cohorts (cases 1–20,
330 min) and the second two cohorts (cases 21–40, 266 min)
(P < 0.0001) and between the third and fourth cohorts
(266 min) and the latter six groups (210 min) (P < 0.002).
CUSUM analysis is illustrated in Fig. 2(a). This confirmed the
two distinct phases of the learning curve in the first 40 cases,
followed by a predominantly downward slope indicating that
OTs beyond the learning curve continued to gradually
improve. Figure 2(b–d) shows the learning curve phases indi-
vidually. Moreover, when plotted on a C-chart (Fig. 3), cases
performed beyond the learning curve exhibited minimal varia-
tions from the mean, indicating that RDP was being performed
with reliable consistency and efficiency once the learning curve
had been attained.
Perioperative outcomes in relation to the learning
curve
Based on the identification of the OT learning curve of 40
cases, an analysis of perioperative outcomes comparing those
in the learning curve cohort (first 40 cases) with those in the
later experience (post-learning curve cohort: cases 41–100) was
performed (Tables 1 and 2). Both groups were homogeneous
with respect to all preoperative demographics (Table 1). A sig-
nificant reduction in the rate of 90-day readmission was
observed after the learning curve had been surpassed
(P = 0.041). Additionally, marked reductions in the incidence
of clinically significant Grade B or C fistulae (27.5% versus
11.7%; P = 0.062), and Clavien–Dindo Grade III or IV compli-
cations (20.0% versus 10.0%; P = 0.239) were observed after
40 cases (Table 2).
Outcomes in patients with and without PDA
A subgroup analysis of patients with PDA (30.0%) was also
performed (data not shown). Although PDA patients were
older (66.3 years) than their non-PDA counterparts
(57.5 years) (P < 0.001), all other baseline demographics were
similar across both groups and there were no significant differ-
ences in operative (mean OT: 244 min versus 246 min, respec-
tively; median EBL: 150 ml in both groups; number of
conversions: none versus 2.9%, respectively; all non-significant)
or postoperative (median LoS: 6 days in both groups; Clavien–
Dindo Grade III and IV complications: 13.3% versus 14.3%,
respectively; readmissions: 26.7% versus 25.6%, respectively; all
non-significant) outcomes. The median number of lymph
nodes harvested in PDA patients was 19 and only one patient
had a positive margin (3.3%).
Discussion
The cumulative summation technique has been effectively used
to evaluate learning curves for surgical procedures22,23 because
it displays the variance from the mean on a case-by-case basis.
In this analysis, CUSUM yielded a parabolic curve showing
three distinct phases from which correlates of the RDP learning
curve can be assessed. The mean OTs during the first, second
and third phases were 331 min, 266 min and 210 min, respec-
tively (P < 0.0001). The first steep OT drop (phase 1: 20
patients) can be attributed to increased familiarity with the
‘basics’ of the platform, which include optimal port placement,
robotic docking and an initial rapid improvement in dissection
skills. Phase 2 (cases 20–40) is likely to represent the steep
learning curve that reflects the surgeon’s development of ability
to compensate for reduced haptic feedback with improved
visualization and mastery of tissue manipulation. Phase 3 (case
40 onward) represents optimized (post-learning curve) perfor-
mance metrics for RDP. Importantly, OTs may still gradually
decline in phase 3 as a result of refinements in technique and
the advent of new instruments or technology.
Although the present data indicate that approximately 40
cases were needed to achieve optimal outcomes, it is likely that
the true learning curve may be less steep in other teams wish-
ing to implement this technology today. Robotic surgery has
infiltrated most subspecialties and an increasing number of
surgeons are already utilizing the platform. Additionally, other
reports detailing RDP technique and outcomes have recently
emerged and will provide new adopters with further insight
and guidance. A short learning curve, however, is predicated
on robust prior experience in open and robotic pancreatic sur-
gery; the present surgical team possessed extensive prior expe-
rience in open and laparoscopic pancreatic surgery (but
minimal robotic experience) prior to attempting RDP.2 Thus,
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Figure 1 Operative times in 100 robotic distal pancreatectomies
by consecutive groups of 10 patients per group
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it is likely that phase 1 can be circumvented if all of the above
criteria are present in the new adopter. To the present authors’
knowledge, only one prior report has attempted to identify the
learning curve for LDP; Braga and colleagues analysed 30 con-
secutive LDPs (performed in 2009 and 2010) and noted a sig-
nificant decline in OT after the first 10 cases.24 However, it is
unclear if this cohort represented the authors’ first institutional
LDPs. Furthermore, a trend in OT reductions was also
observed after the 20th case, implying that the true LDP learn-
ing curve might have been longer if the sample size had been
larger. Additionally, the authors had the benefit of significant
laparoscopic experience prior to performing LDP. This is in
sharp contrast with the present authors’ RDP learning curve,
which was predicated on minimal robotic platform experience.
Morbidity after open or minimally invasive DP is not insig-
nificant, even in high-volume institutions.25–30 The primary
morbidity after DP is the development of POPF, the incidence
of which approaches 40% when POPF is characterized rigor-
ously using ISGPF guidelines.28 The present group observed a
decline in the development of clinically significant POPF after
the first 40 cases (P = 0.06). This may be attributable to the
site of pancreatic transection with the linear cutting stapler;
with increasing experience, this group has come to transect all
PDA pancreata at the neck in order to maximize negative
margin distance and improve lymph node yield. As the
parenchyma here is thinnest, clinically significant pancreatic
fistulae may have been avoided. Other than the reduction in
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Figure 2 (a) CUSUM analysis of operative time showing three
distinct phases of the learning curve for robotic distal
pancreatectomy (RDP). CUSUMORT is plotted on the vertical axis
against the respective case number. (b) Phase 1 indicates a rise in
CUSUMORT with relative stabilization at case 20. (c) Phase 2
demonstrates a reduction in CUSUMORT after case 20. This is
followed by a very slow increase in CUSUMORT with stabilization
near case 40. (d) Phase 3 demonstrates a significant reduction in
CUSUMORT after case 40
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OT between the early and late phases, the analysis did not
reveal any other factors that would have led to a reduction in
Grade B and C leaks. Notably, the method of transecting the
gland (91.0% stapler, 9.0% electrocautery with robotic overs-
ewing of the cut edge) did not influence the leak rate. How-
ever, this reduction in clinically significant POPF is likely to
have led to the significant decline in readmissions in the latter
part of the experience (from 40.0% to 20.0%; P = 0.041). The
association between POPF and readmission is well documented
and was confirmed in this analysis: 12 of the 16 readmissions
(75.0%) in the early part of the present experience occurred in
patients with known leaks (Grade B or C, n = 10; Grade A,
n = 2), whereas six of 12 readmissions (50.0%) in the later
part of the experience occurred in patients with known leaks
(Grade B, n = 4; Grade A, n = 2).
The median EBL of 150 ml and conversion rate of 2.0%
identified in the present series compare favourably with
equivalent data for most LDP series.3,5,9,22 Unlike in pancreati-
coduodenectomy, in which morbidity is much higher as a
result of the extent of dissection and multiple anastomoses, the
ability to complete RDP without conversion (particularly for
PDA) may be the only benefit to distinguish the method from
LDP. However, this advantage is of paramount importance
because conversions are associated with higher EBL, positive
(R1) margins and increased morbidity.11 Thus, even in the
PDA cohort, in which average tumour size was 3.6 cm, EBL
was maintained at 150 ml, the R1 rate was low, and no con-
versions were required.
The present analysis has important limitations. Firstly, as
three surgeons were involved in the majority of cases (some-
times in a two attending approach in the initial implementa-
tion phase), it is particularly difficult to ascertain an individual
surgeon’s learning curve. Consequently, this learning curve
represents that of a ‘group’ of surgeons performing RDP in
similar fashion. Secondly, the learning curve may actually be
shorter than 40 cases for surgeons already experienced in some
facets of the robotic platform; indeed new attending staff (and
fellows) with prior robotic experience and training have –
anecdotally – been able to climb this learning curve much
more rapidly. Thirdly, the present learning curve analysis is
based solely on OT because this was the only metric to display
constant significant improvements when outcomes were exam-
ined in 10 chronologically ordered groups; all other metrics
failed to show such a constant significant improvement, proba-
bly as a result of small sample sizes. Finally, during this study
period, 75 open DPs (ODPs) and 107 LDPs were performed at
the study institution (mostly during 2008–2010). Although
comparisons among these three modalities (ODP, LDP and
RDP) would have been ideal, these were not feasible because
the vast majority of DPs performed by the authors from 2011
onward were RDPs. In conclusion, this report identifies the
RDP learning curve to be approximately 40 cases in a group of
surgeons with minimal prior robotic experience. Familiarity
with the platform, mentorship and dedicated training are likely
to contribute to the significant shortening of the learning curve
in future adopters.
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